218 related articles for article (PubMed ID: 25491660)
1. Moderate to severe psoriasis patients' subjective future expectations regarding health-related quality of life and longevity.
Rencz F; Holló P; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Balogh O; Herédi E; Herszényi K; Jókai H; Brodszky V; Gulácsi L
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1398-405. PubMed ID: 25491660
[TBL] [Abstract][Full Text] [Related]
2. Subjective health expectations of patients with age-related macular degeneration treated with antiVEGF drugs.
Péntek M; Brodszky V; Biró Z; Kölkedi Z; Dunai Á; Németh J; Baji P; Rencz F; Gulácsi L; Resch MD
BMC Geriatr; 2017 Oct; 17(1):233. PubMed ID: 29017463
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of health-related quality of life in psoriasis patients in Hungary].
Poór AK; Sárdy M; Cserni T; Brodszky V; Holló P; Gulácsi L; Remenyik É; Szegedi A; Rencz F; Péntek M
Orv Hetil; 2018 May; 159(21):837-846. PubMed ID: 29779387
[TBL] [Abstract][Full Text] [Related]
4. Health status and quality of life in patients with psoriasis: an Iranian cross-sectional survey.
Moradi M; Rencz F; Brodszky V; Moradi A; Balogh O; Gulácsi L
Arch Iran Med; 2015 Mar; 18(3):153-9. PubMed ID: 25773688
[TBL] [Abstract][Full Text] [Related]
5. Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn's disease.
Péntek M; Gulácsi L; Herszényi L; Banai J; Palatka K; Lakatos PL; Brodszky V; Rencz F
Colorectal Dis; 2021 Jan; 23(1):105-113. PubMed ID: 32920967
[TBL] [Abstract][Full Text] [Related]
6. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B;
Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
[TBL] [Abstract][Full Text] [Related]
7. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
Pickard AS; Gooderham M; Hartz S; Nicolay C
J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
[TBL] [Abstract][Full Text] [Related]
8. Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis.
Luger TA; Barker J; Lambert J; Yang S; Robertson D; Foehl J; Molta CT; Boggs R
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):896-904. PubMed ID: 19453794
[TBL] [Abstract][Full Text] [Related]
9. Extent of Exacerbation of Chronic Health Conditions by Visual Impairment in Terms of Health-Related Quality of Life.
Park SJ; Ahn S; Woo SJ; Park KH
JAMA Ophthalmol; 2015 Nov; 133(11):1267-75. PubMed ID: 26379209
[TBL] [Abstract][Full Text] [Related]
10. Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists.
Péntek M; Gulácsi L; Rojkovich B; Brodszky V; van Exel J; Brouwer WB
Eur J Health Econ; 2014 May; 15 Suppl 1():S83-92. PubMed ID: 24832839
[TBL] [Abstract][Full Text] [Related]
11. Mapping DLQI on EQ-5D in psoriasis: transformation of skin-specific health-related quality of life into utilities.
Blome C; Beikert FC; Rustenbach SJ; Augustin M
Arch Dermatol Res; 2013 Apr; 305(3):197-204. PubMed ID: 23266843
[TBL] [Abstract][Full Text] [Related]
12. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
13. Expectations regarding length and health related quality of life: some empirical findings.
Brouwer WB; van Exel NJ
Soc Sci Med; 2005 Sep; 61(5):1083-94. PubMed ID: 15955408
[TBL] [Abstract][Full Text] [Related]
14. Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary.
Herédi E; Rencz F; Balogh O; Gulácsi L; Herszényi K; Holló P; Jókai H; Kárpáti S; Péntek M; Remenyik É; Szegedi A; Brodszky V
Eur J Health Econ; 2014 May; 15 Suppl 1():S111-9. PubMed ID: 24832842
[TBL] [Abstract][Full Text] [Related]
15. Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
Kalb RE; Blauvelt A; Sofen HL; Chevrier M; Amato D; Calabro S; Wang J; Schenkel B; Gottlieb AB
J Drugs Dermatol; 2013 Aug; 12(8):874-80. PubMed ID: 23986160
[TBL] [Abstract][Full Text] [Related]
16. Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary.
Péntek M; Hajdu O; Rencz F; Beretzky Z; Brodszky V; Baji P; Zrubka Z; Major K; Gulácsi L
Eur J Health Econ; 2019 Jun; 20(Suppl 1):17-30. PubMed ID: 31111403
[TBL] [Abstract][Full Text] [Related]
17. Analysis of three outcome measures in moderate to severe psoriasis: a registry-based study of 2450 patients.
Norlin JM; Steen Carlsson K; Persson U; Schmitt-Egenolf M
Br J Dermatol; 2012 Apr; 166(4):797-802. PubMed ID: 22182212
[TBL] [Abstract][Full Text] [Related]
18. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis.
Revicki D; Willian MK; Saurat JH; Papp KA; Ortonne JP; Sexton C; Camez A
Br J Dermatol; 2008 Mar; 158(3):549-57. PubMed ID: 18047521
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
[TBL] [Abstract][Full Text] [Related]
20. [Disease burden of psoriasis associated with psoriatic arthritis in Hungary].
Rencz F; Brodszky V; Péntek M; Balogh O; Remenyik E; Szegedi A; Holló P; Kárpáti S; Jókai H; Herszényi K; Herédi E; Szántó S; Gulácsi L
Orv Hetil; 2014 Nov; 155(48):1913-21. PubMed ID: 25417138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
